Oak Bay Biosciences

Developing the first therapy for Stargardt disease - genetic blindness
Health & Wellness
Social Impact Driven

Share

Info

$615,224 completed
$7,500 processing
of $1,000,000 CAD
62%
10
days left: closing December 10, 2021
32
investors
*No closing minimum
$250
minimum investment